USPTO Patent Application for Fiber-Based Prebiotic Dietary Supplements
Summary
The USPTO has published a patent application (US20260083763A1) for liquid compositions containing fiber as a prebiotic dietary supplement. The application details formulations designed to maintain or improve gut microbiome health.
What changed
This document is a USPTO patent application (US20260083763A1) filed on September 25, 2025, for liquid compositions comprising fiber as a prebiotic dietary supplement. The invention aims to maintain and improve gut microbiome and overall gut health. The application includes details on the therapeutic ingredients, fiber content, and manufacturing processes.
As this is a patent application, it does not impose immediate regulatory obligations. However, companies involved in the development or manufacturing of dietary supplements, particularly those targeting gut health, should be aware of this intellectual property filing. It may impact future product development strategies and patent landscapes in the pharmaceutical and food manufacturing sectors.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
LIQUID COMPOSITIONS COMPRISING FIBER
Application US20260083763A1 Kind: A1 Mar 26, 2026
Inventors
Katherine C. Dectis, Nancy Edge, Patricia L. Golas, Jian Guo Dong, Ibukunoluwa Adesuwa Oluwawemitan
Abstract
Liquid compositions comprising one or more therapeutic ingredients including fiber and processes of manufacturing the same. Such compositions can be used as a prebiotic dietary supplement to maintain and/or improve the gut microbiome and overall gut health of a human.
CPC Classifications
A61K 31/702 A61K 9/0095 A61K 9/08 A61K 31/718 A61K 47/12
Filing Date
2025-09-25
Application No.
19339624
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.